Scientific AI Companies
Explore 5 Scientific AI companies in our AI directory. Leading companies include Lila Sciences, EvolutionaryScale, Aaru.
Lila Sciences
San Francisco, United States
Lila Sciences builds AI Science Factories - automated laboratories guided by AI for continual scientific discovery. Raised $350M Series A.
EvolutionaryScale
New York, United States
EvolutionaryScale develops generative AI models for de novo protein design and understanding, most notably the ESM-3 family of protein language models. Their core innovation lies in leveraging large-scale protein sequence data to enable the creation of novel proteins with desired functions – demonstrated by the successful in silico design and synthesis of esmGFP, a fluorescent protein evolved beyond natural limitations. Targeting pharmaceutical companies, biotechnology firms, and academic research labs, EvolutionaryScale provides access to ESM-3 via API and open-source models (ESM-3-open) to accelerate drug discovery and protein engineering efforts, backed by $142M in seed funding.
Aaru
San Francisco, United States
Aaru builds AI-powered platforms like Knowledgeworks and Chemformer specifically for accelerating drug discovery and materials science research. Their core innovation lies in applying generative AI and knowledge graphs to predict novel molecular properties and design compounds with desired characteristics, significantly reducing reliance on traditional trial-and-error methods. Achieving unicorn status with a $1 billion valuation, Aaru partners with pharmaceutical companies and government agencies to address complex scientific challenges and expedite the development of new therapeutics and advanced materials.
Iris.ai
Oslo, Norway
Iris.ai uses AI to help researchers navigate scientific literature, automatically analyzing and extracting insights from research papers.
Google DeepMind
London, United Kingdom
Google DeepMind is a world leader in artificial intelligence research. Known for AlphaGo, AlphaFold, and Gemini. Merged with Google Brain in 2023.